
MSN Group to unveil drug to treat epilepsy
The Hindu
Drugmaker MSN Group is focussed on introducing generic products for various therapies at a fraction of the innovator’s product price once the patent expires.
“In the next 5-6 years, MSN will bring products, once the patent expires, at one-tenth of the cost,” executive director Bharat Reddy said, announcing that MSN will unveil anti-epilepsy drug Brivanext in India in the next few days.
More Related News

About 923 families of Nagarathar community arrived from across the globe at Nattarasankottai in Sivaganga district to celebrate the traditional ‘Sevvai Pongal’ festival. This annual event serves as a massive international reunion for the Nagarathar community people. Local residents said while many might miss major holidays like Pongal or Deepavali, they made every effort to attend Sevvai Pongal, which was held on the first Tuesday following Pongal. This tradition had been upheld by the community for over two centuries.












